Pair Name | Radix ranunculus temate saponins, Paclitaxel | ||
Phytochemical Name | Radix ranunculus temate saponins (PubChem CID: / ) | ||
Anticancer drug Name | Paclitaxel (PubChem CID: 36314 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Radix ranunculus temate saponins, Paclitaxel | |||
Disease Info | [ICD-11: 2C73] | Ovarian cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | COL3A1 | hsa1281 |
In Vitro Model | A2780 | Ovarian endometrioid adenocarcinoma | Homo sapiens (Human) | CVCL_0134 |
OVCAR-3 | High grade ovarian serous adenocarcinoma | Homo sapiens (Human) | CVCL_0465 | |
SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens (Human) | CVCL_0532 | |
In Vivo Model | A2780 cells (1×10⁶) were injected subcutaneously into the back of six-week-old BALB/c nu/nu female mice. | |||
Result | Combination of Taxol and RRTS may be a novel treatment strategy for patients with TR ovarian cancer. |
No. | Title | Href |
---|---|---|
1 | Radix ranunculus temate saponins sensitizes ovarian cancer to Taxol via upregulation of miR-let-7b. Exp Ther Med. 2022 May;23(5):315. doi: 10.3892/etm.2022.11244. | Click |